IDEAYA BIOSCIENCES INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$31.96
-2.83%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-15.5%
3 months
-9.7%
6 months
+13.4%
1 year
+1.1%
Year to date
-7.5%
52-week range
$27.60 – $42.48
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$3.08B
P/E
-17.6
P/B
2.6
P/S
13.2
Revenue
$234.13M
Net income
-$175.02M
Diluted EPS
-1.94
Gross margin
100.00%
Net margin
-74.80%
Return on equity
-16.50%
Total debt
$29.31M
Cash
$273.87M
Free cash flow
-$113.87M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $8.86M | -$112.45M | 100.00% | -1269.60% | -$89.08M |
| Mar 31, 2026 | $6.56M | -$98.54M | 100.00% | -1502.10% | -$76.14M |
| Dec 31, 2025 | $10.88M | -$83.27M | 100.00% | -765.70% | -$90.83M |
| Sep 30, 2025 | $207.83M | $119.24M | 100.00% | 57.40% | $142.17M |
| Jun 30, 2025 | $0 | -$77.49M | — | — | -$63.14M |
| Mar 31, 2025 | $0 | -$72.18M | — | — | -$61.67M |
| Dec 31, 2024 | $7M | -$130.31M | 100.00% | -1861.60% | -$122.76M |
| Sep 30, 2024 | $0 | -$51.82M | — | — | -$49.69M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent IDYA news
All market newsNo ticker-linked stories are in the current archive.